- Why PatSeerOverview​
Worldwide Patents, SEPs, Litigations, NPEs, NPL, Quality Scores & more
Simple, Smart, feature-rich, and powerful enough to impress the Pro’s
Why Clients Love UsHere from users who chose PatSeer.
See why PatSeer is the leading patent research software
About UsWhat drives us, values, milestones
Meet the team behind PatSeer's fast-growing IP platform
- PlatformEditions
Business Intelligence and insights over connected IP data
Fully featured Research and Collaboration platform for corporate teams
Zero compromise search platform for patent professionals
End-to-end IP knowledge and workflow management solution
Simple company-wide IP search and share solution for R&D
What's newFind out about the latest updates
- SolutionsCustomer Type
See how PatSeer helps experienced patent professionals
Learn why PatSeer is a knowledge management solution
Use PatSeer to support your IP workflows
Create a more inclusive client experience using PatSeer
Screen your ideas like a pro
Evaluate build vs buy opportunities
RequirementManage portfolios effectively
Locate the right IP monetization opportunities
Reveal potential business & IP-related insights
Uncover new technology areas
Generate detailed technology landscapes
- Pricing
- ResourcesLearn
Read best practices & stay up-to date with news
Join live demos, product updates and best practices webinars
Get trendy, interesting and thought-provoking facts and statistics on IP
Access PatSeer’s newsletter ‘PatNews’ and accelerate your innovation potential
Get access to free e-book on practical patent searching
Explore our latest research and insights to stay ahead of the curve
ClientsSee why PatSeer is the leading patent research software
Meet the customers who chose PatSeer
Access PatSight’s presentations and discussions for free today
News & EventsRead the latest news, reviews and articles on PatSeer
Stay updated on the most recent events and conferences
Come join the PatSeer team! We are currently hiring
- Contact Us
- Cookie Policy
- Privacy Statement
Digital biomarker technology is used to capture physiological and behavioral data, diagnose diseases and predict outcomes. It is available in the form of portables, wearables, implantables and digestibles. Popular examples of digital biomarkers include FitBits, Oura rings and Apple Watches. The digital biomarker market is expected to witness tremendous growth and according to the latest research reports, it is estimated to reach around USD 24.5-25 billion by 2030, growing at a rate of 36-37% during the forecast period.
To get a clearer picture of this rapidly growing technology, we conducted a study to evaluate the country-wise distribution of patents filed by different companies over the last 10 years. We created a search query in PatSeer using keywords related to digital biomarkers and combined it with relevant IPC and CPC classes. The final search query resulted in a set of 3000+ patent families which was then studied further to understand the patent filing trends and top players in each country.
Patent filings of top companies across various jurisdictions
We used PatSeer’s Geo protection Growth Chart to view the growth in filings for each country from 2010 to the present.
Figure 1: Digital biomarker growth in patent applications per country (2010-2022)
Note:Â Patents filed in 2021 and 2022 may not have been published yet, so figures for these years should not be considered indicative of a trend.
As you can see from the figure above, the digital biomarker market has increased exponentially in the last 10 years. China’s patent filing rate is almost 7 times higher than it was in 2013, with 141 patents in 2013 and 1051 patents in 2022.
Similarly, US patent filing rates also surged upwards by approximately 250%, with 270 patents in 2013 and 914 in 2022. Other countries like Korea, India, Japan and Taiwan didn’t have a lot of patent filings earlier but are now witnessing aggressive patenting activity.
Analysis of key players
From the retrieved patent dataset, we identified the prominent assignees filing patents for digital biomarker technology. We found that some of them are leading multidisciplinary companies who are becoming key market players in this field.
Figure 2: Top Assignees
To gain a better understanding of these top assignees’ global patenting activity, we plotted a graph that depicts the number of patent families across their chosen priority countries.
Figure 3: No. of patent families filed by top assignees across priority countries
We found that Philips is the top assignee and they are protecting their inventions in many leading countries such as the US, China, Japan, EP, and India. Interestingly, Medtronic, Panasonic, and Samsung have also filed multiple patents in China apart from their countries of origin.
Conclusion
In short, our study found that leading companies had filed the most digital biomarker patents in the US and China. However, Japan, Korea, and India are catching up quickly with their high patenting activity.